Savarirayan, R., De Bergua, J. M., Arundel, P., McDevitt, H., Cormier-Daire, V., Saraff, V., Skae, M., Delgado, B., Leiva-Gea, A., Santos-Simarro, F., Salles, J. P., Nicolino, M., Rossi, M., Kannu, P., Bober, M. B., Phillips, J., Saal, H., Harmatz, P., Burren, C., Gotway, G., Cho, T., Muslimova, E., Weng, R., Rogoff, D., Hoover-Fong, J., & Irving, M. (2022). infigratinib in children with achondroplasia: the PROPEL and PROPEL 2 studies. Therapeutic advances in musculoskeletal disease, 14, . http://access.bl.uk/ark:/81055/vdc_100169881084.0x00004e